Company
Janssen Biotech, Inc.
20 Case(s) (Last 5 Years)
Patents Prosecuted
| Application number | Title of the patent | IPC | Filing Date | Decision Date |
|---|---|---|---|---|
| 16682551 | Control of trace metals during production of anti-CD38 antibodies | C07K | Nov 12, 2019 | Apr 24, 2023 |
| 16679778 | THERAPEUTIC AGENTS AND USES THEREOF | A61K, G01N, C07K | Nov 10, 2019 | Jun 2, 2022 |
| 16673750 | Protoxin-II variants and methods of use | A61K, C07K | Nov 3, 2019 | Aug 9, 2021 |
| 16598920 | Differentiation of human embryonic stem cells | C12N, A61K | Oct 9, 2019 | Jul 24, 2023 |
| 16586786 | Differentiation of human embryonic stem cells | C12N | Sep 26, 2019 | Nov 21, 2022 |
| 16582279 | Pancreatic endocrine cells and methods thereof | C12N, A61K | Sep 24, 2019 | Feb 5, 2024 |
| 17274512 | METHOD OF PROVIDING SAFE ADMINISTRATION OF AN ANTI-CD154 ANTIBODY | A61K, C07K | Sep 23, 2019 | |
| 16578178 | Oncolytic herpes simplex virus and therapeutic uses thereof | A61K, C12N | Sep 19, 2019 | Oct 18, 2021 |
| 16540388 | Method for treating pre-type 1 diabetes in a human subject | C07K, A61M, A61P, A61K | Aug 13, 2019 | Sep 20, 2021 |
| 16540543 | TREATMENT OF HIDRADENITIS SUPPURATIVA | A61P, C07K | Aug 13, 2019 | Feb 2, 2021 |
| 16540657 | ENCAPSULATED INTESTINAL MIDGUT ENDODERM CELLS | A61K, C12N | Aug 13, 2019 | |
| 16539401 | Methods for lowering blood glucose | A61K | Aug 12, 2019 | Jun 27, 2022 |
| 16460754 | Subcutaneous Formulations Of Anti-CD38 Antibodies And Their Uses | A61P, A61K, C07K | Jul 1, 2019 | Dec 10, 2020 |
| 16435428 | Differentiation of human embryonic stem cells into single hormonal insulin positive cells | C12N | Jun 6, 2019 | Jul 4, 2022 |
| 16418328 | PSMA binding agents and uses thereof | C07K | May 20, 2019 | Sep 4, 2023 |
| 16418082 | Anti-CD3 antibodies and uses thereof | C07K, A61K, A61P | May 20, 2019 | Mar 13, 2023 |
| 16418420 | Anti-CD33 antibodies, anti-CD33/anti-CD3 bispecific antibodies and uses thereof | A61P, A61K, C07K | May 20, 2019 | Oct 10, 2022 |
| 16417889 | Monospecific and multispecific anti-TMEFF2 antibodies and their uses | A61P, A61K, C07K | May 20, 2019 | Jan 8, 2024 |
| 16412701 | Methods of Treating Cancers and Enhancing Efficacy of T Cell Redirecting Therapeutics | A61P, A61K, C07K | May 14, 2019 | |
| 17048865 | TREATMENT OF ATOPIC DERMATITIS | A61P, A61K, C07K | Apr 23, 2019 | Oct 9, 2023 |